or Try an Advanced Search...

    Takeda Pharmaceutical Company Stocks List

    Symbol Grade Name % Change
    ALNY D Alnylam Pharmaceuticals, Inc. -0.73
    AMGN B Amgen Inc. -3.79
    CRDF D Cardiff Oncology, Inc. -1.70
    GOSS F Gossamer Bio, Inc. 5.50
    ITCI B Intra-Cellular Therapies Inc. 3.21
    LXRX D Lexicon Pharmaceuticals, Inc. 5.17
    OVID F Ovid Therapeutics Inc. -1.31
    RXRX F Recursion Pharmaceuticals, Inc. 1.13
    STTK B Shattuck Labs, Inc. 3.71
    TAK F Takeda Pharmaceutical Company Limited -0.07
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Medicine Cancer Prostate Cancer Solid Tumors Advanced Solid Tumors Clinical Development Clinical Trial Diabetes Disorders Drug Discovery Drugs Hematology Human Diseases Immunology Lymphoma Monoclonal Antibodies Neuroscience

    Related ETFs - A few ETFs which own one or more of the above listed Takeda Pharmaceutical Company stocks.

    Symbol Grade Name Weight
    BBH C Market Vectors Biotech ETF 16.98
    IBBQ C Invesco Nasdaq Biotechnology ETF 11.62
    IBB D iShares Nasdaq Biotechnology Index Fund 11.39
    FBT D First Trust Amex Biotech Index Fund 10.53
    BIS D ProShares UltraShort Nasdaq Biotechnology 9.95
    View all Takeda Pharmaceutical Company ETFs...
    Compare ETFs
    Compare BBH to FBT Compare IBB to FBT Compare IBBQ to FBT

        Takeda Pharmaceutical Company Stocks Recent News

        Date Stock Title
        May 6 ITCI Intra-Cellular Therapies Q1 2024 Earnings Preview
        May 6 LXRX Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript
        May 6 GOSS UPDATE 1-Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
        May 6 GOSS Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
        May 6 AMGN Investors Pile Into Amgen in Search of Next Obesity Drug Payout
        May 5 AMGN Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
        May 5 ALNY The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
        May 5 LXRX Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2024 Earnings Call Transcript
        May 4 AMGN Amgen First Quarter 2024 Earnings: EPS Misses Expectations
        May 4 AMGN Amgen Could Become A Real Contender In The Obesity Market
        May 4 CRDF Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations
        May 4 STTK Shattuck Labs First Quarter 2024 Earnings: Beats Expectations
        May 4 STTK Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results
        May 4 AMGN Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
        May 3 AMGN Why Amgen Stock Zoomed Nearly 12% Higher Today
        May 3 RXRX Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know
        May 3 AMGN Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 AMGN Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 AMGN Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending
        May 3 ALNY Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Medicine Cancer Prostate Cancer Solid Tumors Advanced Solid Tumors Clinical Development Clinical Trial Diabetes Disorders Drug Discovery Drugs Hematology Human Diseases Immunology Lymphoma Monoclonal Antibodies Neuroscience
        Takeda Pharmaceutical Company

        The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical and biopharmaceutical company. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 49,578 employees worldwide and achieved US $19.299 billion in revenue during the 2018 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.
        In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

        More about Takeda Pharmaceutical Company
        Browse All Tags